Both in Biotechnology
Estrella Immunopharma vs Jasper Therapeutics
Over the past year ESLA returned −61.3% and JSPR returned −74.9%; their daily moves had a correlation of 0.07.
ESLA −61.3% JSPR −74.9%Growth of $1, one year, split-adjusted
| Metric | ESLA | JSPR |
|---|---|---|
| Price | $0.4601 | $0.6254 |
| Market cap | $20.0M | $20.8M |
| Today | +6.65% | −0.10% |
| 1 month | −34.7% | −10.6% |
| 6 months | −55.3% | −30.5% |
| Year to date | −70.5% | −65.8% |
| 1 year | −61.7% | −74.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $146.7K | $7.3M |
| Dividend yield | — | — |
| Volatility (60d) | 76.0% | 100.6% |
| Short % of float | 1.0% | 25.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).